Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Molecular and Cellular Biology
|
June 1, 1989
Identification of a novel bone marrow-derived B-cell progenitor population that coexpresses B220 and Thy-1 and is highly enriched for Abelson leukemia virus targets
G F Tidmarsh, S Heimfeld, C A Whitlock, et al.
Molecular and Cellular Biology
|
October 1, 1996
Identification of a novel bone marrow-derived B-cell progenitor population that coexpresses B220 and Thy-1 and is highly enriched for Abelson leukemia virus targets
G F Tidmarsh, S Heimfeld, C A Whitlock, et al.
Blood
|
June 15, 1993
In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits
L C Griffin, G F Tidmarsh, L C Bock, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 15, 1989
The early B lineage antigen BP-1 and the transformation-associated antigen 6C3 are on the same molecule
Q Wu, G F Tidmarsh, P A Welch, et al.
The Journal of Experimental Medicine
|
March 1, 1987
Expression of the 6C3 antigen on murine hematopoietic neoplasms. Association with expression of abl, ras, fes, src, erbB, and Cas NS-1 oncogenes but not with myc
H C Morse, G F Tidmarsh, K L Holmes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2000
Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas
J M Vose, R L Wahl, M Saleh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2001
Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas
M S Kaminski, A D Zelenetz, O W Press, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Molecular and Cellular Biology
|
June 1, 1989
Identification of a novel bone marrow-derived B-cell progenitor population that coexpresses B220 and Thy-1 and is highly enriched for Abelson leukemia virus targets
G F Tidmarsh, S Heimfeld, C A Whitlock, et al.
Molecular and Cellular Biology
|
October 1, 1996
Identification of a novel bone marrow-derived B-cell progenitor population that coexpresses B220 and Thy-1 and is highly enriched for Abelson leukemia virus targets
G F Tidmarsh, S Heimfeld, C A Whitlock, et al.
Blood
|
June 15, 1993
In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits
L C Griffin, G F Tidmarsh, L C Bock, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 15, 1989
The early B lineage antigen BP-1 and the transformation-associated antigen 6C3 are on the same molecule
Q Wu, G F Tidmarsh, P A Welch, et al.
The Journal of Experimental Medicine
|
March 1, 1987
Expression of the 6C3 antigen on murine hematopoietic neoplasms. Association with expression of abl, ras, fes, src, erbB, and Cas NS-1 oncogenes but not with myc
H C Morse, G F Tidmarsh, K L Holmes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2000
Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas
J M Vose, R L Wahl, M Saleh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2001
Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas
M S Kaminski, A D Zelenetz, O W Press, et al.
Page
of 2